Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults
Clinical trial NCT02148328 · COMPLETED
Trial details
- NCT number
- NCT02148328
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-10-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.